Health7 months ago
Stanford Medicine trial: 15-day paxlovir therapy safe, but no clear benefit against long COVID | News Center
Midway through the study, the data were submitted to an independent group for preliminary analysis, and the researchers determined that safety was good but that benefits...
Recent Comments